• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XU Manli, WANG Chang, WANG Nan, HE Hongpeng, ZHANG Tongcun, LUO Xuegang. MALAT1 upregulates SMYD3 by competition with miR-124 and promotes proliferation and migration of breast cancer cells[J]. Journal of China Pharmaceutical University, 2019, 50(3): 344-351. DOI: 10.11665/j.issn.1000-5048.20190311
Citation: XU Manli, WANG Chang, WANG Nan, HE Hongpeng, ZHANG Tongcun, LUO Xuegang. MALAT1 upregulates SMYD3 by competition with miR-124 and promotes proliferation and migration of breast cancer cells[J]. Journal of China Pharmaceutical University, 2019, 50(3): 344-351. DOI: 10.11665/j.issn.1000-5048.20190311

MALAT1 upregulates SMYD3 by competition with miR-124 and promotes proliferation and migration of breast cancer cells

More Information
  • To investigate whether lncRNA MALAT1 affects the migration and proliferation of breast cancer cells through the regulation with histone methyltransferase SMYD3, the endogenous MALAT1 in the MCF-7 and MDA-MB-231 breast cancer cells were knocked down by siRNA, and then the migration and proliferation of cells were detected by wound healing migration and MTT assay. The effects of si-MALAT1 on the mRNA and protein levels of miRNA-124, SMYD3 and its downstream genes were detected by Real time PCR and Western blot. The results showed that siRNA-targeted knockdown of MALAT1 reduced the migration and proliferation of breast cancer cells, and inhibited the transcriptional expression of SMYD3 and its downstream genes, including N-cadherin, MYL9, MMP9 and CYR61, and up-regulated miR-124. Overexpression of miR-124 reduced the expression of SMYD3 in breast cancer cells, and knockdown of MALAT1 attenuated the promotion of SMYD3 protein expression by miR-124 inhibitors. In addition, SMYD3 overexpression activated MALAT1 transcription, whereas siRNA interference with SMYD3 downregulated MALAT1. These results indicate that LncRNA MALAT1 acted as a competing endogenous RNA(ceRNA)of miR-124 to regulate expression of SMYD3 in breast cancer cells, and SMYD3 can activate the transcription of MALAT1, which will affect the proliferation and migration of breast cancer cells.
  • [1]
    Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
    [2]
    Hamamoto R,Furukawa Y,Morita M,et al.SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells[J].Nat Cell Biol,2004,6(8):731-740.
    [3]
    Liu Y,Luo XG,Deng JY,et al.SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma[J].Tumour Biol,2015,36(4):2685-2694.
    [4]
    Luo XG,Zhang CL,Zhao WW,et al.Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells[J].Cancer Lett,2014,344(1):129-137.
    [5]
    Fuji T,Tsunesumi S,Yamaguchi K,et al.SMYD3 is required for the development of cardiac and skeletal muscle in zebrafish[J].PLoS One,2011,6(8):e23491.
    [6]
    Tracy CM,Warren JS,Szulik M,et al.The Smyd family of methyltransferases:role in cardiac and skeletal muscle physiology and pathology[J].Curr Opin Physiol,2018,1:140-152.
    [7]
    Zeng B,Li ZH,Chen RF,et al.Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3[J].FEBS Lett,2012,586(19):3271-3278.
    [8]
    Zhang H,Chen ZH,Wang XX,et al.Long non-coding RNA:a new player in cancer[J].J Hematol Oncol,2013,6:37.
    [9]
    Chen HY,Meng T.Effect of LncRNA MALAT1 on proliferation and apoptosis of human umbilical vein endothelial cells[J].Chin J Public Health(中国公共卫生),2016,32(10):1340-1342.
    [10]
    Zhao ZY,Chen CJ,Liu Y,et al.17beta-Estradiol treatment inhibits breast cell proliferation,migration and invasion by decreasing MALAT-1 RNA level[J].Biochem Biophys Res Commun,2014,445(2):388-393.
    [11]
    Arun G,Spector DL.MALAT1 long non-coding RNA and breast cancer[J].RNA Biol,2019.doi: 10.1080/15476286.2019.1592072.
    [12]
    Luo JH,Ren B,Keryanov S,et al.Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas[J].Hepatology,2006,44(4):1012-1024.
    [13]
    Abbastabar M,Sarfi M,Golestani A,et al.lncRNA involvement in hepatocellular carcinoma metastasis and prognosis[J].Excli J,2018,17:900-913.
    [14]
    Wang JQ,Su LP,Chen XH,et al.MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF[J].Biomed Pharmacother,2014,68(5):557-564.
    [15]
    Chang Y,Nu CY.The effect of LncRNA-MALAT1 on the hypoxia-induced gastric cancer metastasis and invasion[J].Mod Oncol(现代肿瘤医学),2015,23(24):3569-3573.
    [16]
    Zhu MH,Zhang CY,Chen DH,et al.lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway [J].Onco Targets Ther,2019,12:1365-1377.
    [17]
    Zhuang M,Zhao SL,Jiang Z,et al.MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility[J].EBioMedicine,2019,41:286-298.
    [18]
    Xi ZW,Si JC,Nan J.LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer[J].Int J Oncol,2019,54(1):239-248.
    [19]
    Dong YQ,Liang GJ,Yuan BQ,et al.MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway[J].Tumour Biol,2015,36(3):1477-1486.
    [20]
    Pang EJ,Yang R,Fu XB,et al.Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer[J].Tumour Biol,2015,36(4):2403-2407.
    [21]
    Cock-Rada AM,Medjkane S,Janski N,et al.SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9[J].Cancer Res,2012,72(3):810-820.
    [22]
    Fenizia C,Bottino C,Corbetta S,et al.SMYD3 promotes the epithelial-mesenchymal transition in breast cancer[J].Nucleic Acids Res,2019,47(3):1278-1293.
    [23]
    Wang Y,Wu CQ,Zhang C,et al.TGF-beta-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions[J].Cancer Lett,2018,436:52-62.
    [24]
    Duan GC,Zhang CL,Xu CK,et al.Knockdown of MALAT1 inhi-bits osteosarcoma progression via regulating the miR34a/cyclin D1 axis[J].Int J Oncol,2019,54(1):17-28.
    [25]
    Chang SM,Hu WW.Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis[J].J Cell Physiol,2018,233(4):3384-3396.
    [26]
    Jiang Y,Li YH,Fang SJ,et al.The role of MALAT1 correlates with HPV in cervical cancer[J].Oncol Lett,2014,7(6):2135-2141.
    [27]
    Zuo YG,Li Y,Zhou ZY,et al.Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer[J].Biomed Pharmacother,2017,95:922-928.
    [28]
    Liu S,Zhou X,Wang XF,et al.Metastasis-associated lung adenocarcinoma transcript 1 modulates oral squamous cell carcinoma invasion in vitro and in vivo[J].Chin J Clin Oncol(中国肿瘤临床),2015,42(9):460-465.
    [29]
    Bamodu OA,Huang WC,Lee WH,et al.Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448[J].BMC Cancer,2016,16:160.
    [30]
    Chou JJ,Wang BY,Zheng TJ,et al.MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42[J].Biochem Biophys Res Commun,2016,472(1):262-269.
    [31]
    Zheng LH,Zhang YH,Fu YJ,et al.Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer[J].Biosci Rep,2019,39(2):1-12.
    [32]
    Luo XG,Lin C,Lu YH,et al.Correlation between SMYD3 and cell proliferation and its effect on cell cycle[J].J China Pharm Univ(中国药科大学学报),2007,38(3):277-282.
    [33]
    Luo XG,Pan H,Liu ZP,et al.The role of SMYD3 in tumorigenesis and development[J].Chem Life(生命的化学),2009,29(2):247-249.
    [34]
    Chen DJ,Liu L,Luo XG,et al.Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells[J].Oncol Lett,2017,14(2):1831-1840.

Catalog

    Article views (588) PDF downloads (879) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return